A detailed history of Alaska Permanent Fund Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alaska Permanent Fund Corp holds 34,971 shares of BMY stock, worth $1.73 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
34,971
Previous 126,995 72.46%
Holding current value
$1.73 Million
Previous $6.89 Million 78.91%
% of portfolio
0.02%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$40.25 - $52.99 $3.7 Million - $4.88 Million
-92,024 Reduced 72.46%
34,971 $1.45 Million
Q1 2024

Apr 09, 2024

SELL
$47.98 - $54.4 $5.86 Million - $6.65 Million
-122,211 Reduced 49.04%
126,995 $6.89 Million
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $2.22 Million - $2.65 Million
-45,855 Reduced 15.54%
249,206 $12.8 Million
Q3 2023

Oct 31, 2023

BUY
$57.89 - $64.73 $160,528 - $179,496
2,773 Added 0.95%
295,061 $17.1 Million
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $7.14 Million - $7.93 Million
112,039 Added 62.16%
292,288 $18.7 Million
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $198,249 - $234,755
2,895 Added 1.63%
180,249 $13 Million
Q3 2022

Oct 31, 2022

BUY
$0.13 - $76.84 $3,822 - $2.26 Million
29,406 Added 19.88%
177,354 $12.6 Million
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $7.85 Million - $8.65 Million
108,134 Added 271.6%
147,948 $11.4 Million
Q1 2022

Apr 26, 2022

BUY
$61.48 - $73.72 $50,044 - $60,008
814 Added 2.09%
39,814 $2.91 Million
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $24,764 - $26,968
400 Added 1.04%
39,000 $2.61 Million
Q3 2020

Oct 29, 2020

BUY
$57.43 - $63.64 $1.09 Million - $1.2 Million
18,920 Added 96.14%
38,600 $2.33 Million
Q1 2020

May 05, 2020

BUY
$46.4 - $67.43 $913,152 - $1.33 Million
19,680 New
19,680 $1.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $105B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.